Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 8, 2020Clinical Pharmacology & TherapeuticsOpen Access

Cannabidivarin for HIV‐Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

LELuca EibachCharité - Universitätsmedizin BerlinSSSimone ScheffelSteriPharm (Germany)MCMadeleine CardebringVivantes Klinikum

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eibach et al. (2020) studied this question.

synapsesocial.com/papers/69d8345a61e2ce1627d18ea1https://doi.org/10.1002/cpt.2016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevalence of chronic pain with neuropathic characteristics in the general population2007 · 1,731 citations
  2. 2pain<i>DETECT</i>: a new screening questionnaire to identify neuropathic components in patients with back pain2006 · 2,307 citations
  3. 3A review of chronic pain impact on patients, their social environment and the health care system2016 · 996 citations
  4. 4Neuropathic pain2007 · 2,745 citations
  5. 5Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis2012 · 71 citations